iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading
iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading |
[17-June-2025] |
SAN FRANCISCO, June 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged false statements exaggerating the capabilities of iRhythm's wearable Zio AT heart event monitor. Current shareholders are encouraged to contact the firm. On June 3, 2025, Judge Jacqueline Scott Corley of the U.S. District Court for the Northern District of California issued an order allowing key claims in a securities fraud lawsuit against iRhythm and CEO Quentin Blackford to move forward. The lawsuit alleges that between November 2021 and August 2024, iRhythm intentionally misled investors by overstating the accuracy and reliability of its Zio AT monitor and misrepresented its suitability for high-risk patients—causing its stock to trade at inflated prices. Judge Corley found that the complaint sufficiently alleged that the defendants made false and misleading statements with an intent to defraud. During this time, company insiders sold approximately $18 million worth of iRhythm stock. The U.S. Department of Justice is also investigating iRhythm's marketing practices. As the truth came out in a series of disclosures from November 2022 through August 2024, iRhythm's stock price fell significantly. We are investigating potential wrongdoing by iRhythm's directors and officers in connection with these allegations. If you own stock in iRhythm, you may have legal options. Please contact us today at https://www.classactionlawyers.com/irhythm to learn more. About Schubert Jonckheer & Kolbe LLP Contact SOURCE Schubert Jonckheer & Kolbe LLP | ||
Company Codes: NASDAQ-NMS:IRTC |